-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RTezBPOE1ama3rv883XzP28zshSX1K/nQgm2pPHI55OwOpQZalslaCMlHOl8y3nU 3v7PPOqyyyKhQlcpKNkk9w== 0000910680-07-001001.txt : 20071106 0000910680-07-001001.hdr.sgml : 20071106 20071106163644 ACCESSION NUMBER: 0000910680-07-001001 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20071106 DATE AS OF CHANGE: 20071106 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Paramount Acquisition Corp CENTRAL INDEX KEY: 0001330487 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 202938469 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-81092 FILM NUMBER: 071218393 BUSINESS ADDRESS: STREET 1: 787 7TH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-554-4300 MAIL ADDRESS: STREET 1: 787 7TH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JODY R. SILVA TRUST CENTRAL INDEX KEY: 0001417650 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 2594 NORTON PLACE CITY: BELLMORE STATE: NY ZIP: 11710 BUSINESS PHONE: 516-785-8633 MAIL ADDRESS: STREET 1: 2594 NORTON PLACE CITY: BELLMORE STATE: NY ZIP: 11710 SC 13D 1 sc13d-jstrust10262007.htm SCHEDULE 13D

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
 

SCHEDULE 13D

Under the Securities Exchange Act of 1934


 

Chem Rx Corporation

(Name of issuer)

Common Stock, $.0001 par value per share

(Title of Class of Securities)

 

69917T103

(CUSIP Number)

The Jody R. Silva Trust

c/o Rosalie Silva, trustee

2594 Norton Place

Bellmore, NY 11710

(516) 785-8633

(Name, address and telephone number of person authorized to receive notices and communications)

October 26, 2007

(Date of event which requires filing of this statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box o

Page 1 of 10 pages




CUSIP No. 69917T103

Schedule 13D

Page 2 of 10



1

NAME OF REPORTING PERSON:

The Jody R. Silva Trust

 

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:

(a) x

(b) o

3

SEC USE ONLY

4

SOURCE OF FUNDS:

OO

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e):

o

6

CITIZENSHIP OR PLACE OF ORGANIZATION:

New York

NUMBER OF

SHARES

7

SOLE VOTING POWER:

88,103 (see footnote 1)

BENEFICIALLY

OWNED BY

8

SHARED VOTING POWER:

6,568,000 (see footnote 2)

EACH

REPORTING

9

SOLE DISPOSITIVE POWER:

88,103 (see footnote 1)

PERSON WITH

10

SHARED DISPOSITIVE POWER:

0

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON: 6,568,000 (see footnote 2)

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:

o

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11): 40.1%

14

TYPE OF REPORTING PERSON:

OO


CUSIP No. 69917T103

Schedule 13D

Page 3 of 10



 

(1) For purposes of Section 13(d), The Jody R. Silva Trust dated January 1, 2005 between Jerry Silva, as grantor, and Rosalie Silva, as trustee, her successors and assigns, by Rosalie Silva, as trustee (the “Trust”) beneficially owns 88,103 shares of the Issuer’s Common Stock (as defined in item 1) with sole voting and sole dispositive power.

(2) Because the Trust is a party to the Voting Agreement described in item 6, the Trust is deemed by Rule 13d-5(b)(1) of the Securities Exchange Act of 1934 to be the beneficial owner of all shares of the Issuer’s Common Stock (as defined in item 1) beneficially owned by each party to the Voting Agreement. Therefore, as a result of such rule, the Trust may be deemed to have shared voting power over all of the 6,568,000 shares of the Issuer’s Common Stock subject to the Voting Agreement, which includes 1,993,000 shares of Common Stock issuable pursuant to warrants which are immediately exercisable. Such 6,568,000 shares of Common Stock represent approximately 40.1% of the outstanding shares of the Issuer’s Common Stock. The Trust disclaims beneficial ownership as to all of the shares of the Issuer’s Common Stock subject to the Voting Agreement, except the shares over which the Trust has dispositive power.




CUSIP No. 69917T103

Schedule 13D

Page 4 of 10



     

Item 1. Security and Issuer.

     The securities to which this statement relates are shares of common stock, par value $.0001 per share (the “Common Stock”), of Chem Rx Corporation, a Delaware corporation (the “Issuer”). The principal executive offices of the Issuer are located at 750 Park Place, Long Beach, New York 11561.

Item 2. Identity and Background.

(a)     

This Statement is being filed by The Jody R. Silva Trust dated January 1, 2005 between Jerry Silva, as grantor, and Rosalie Silva, as trustee, her successors and assigns, by Rosalie Silva, as trustee (the “Trust”).

(b)     

The business address of the Trust is 2594 Norton Place, Bellmore, New York 11710.


(c)     

During the last five years, neither the Trust nor Rosalie Silva (the trustee of the Trust) has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).


(d)     

During the last five years, neither the Trust nor Rosalie Silva (the trustee of the Trust) has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.


(e)     

The Trust is governed by New York law. Rosalie Silva (the trustee of the Trust) is a citizen of the United States.





CUSIP No. 69917T103

Schedule 13D

Page 5 of 10



Item 3. Source and Amount of Funds or Other Consideration.

     The Trust acquired all of its shares of the Issuer's Common Stock on October 26, 2007 upon the closing of the transactions pursuant to the Stock Purchase Agreement (the “Transaction”), dated as of June 1, 2007, as amended on October 8, 2007, (as so amended, the “Stock Purchase Agreement”), among Paramount Acquisition Corp., a Delaware corporation ("Paramount"), B.J.K. Inc., a New York corporation (the “Operating Company ”), and Jerry Silva, Steven C. Silva, Jerry Silva, as Life Tenant, and Steven C. Silva, as Remainderman, The Jody R. Silva Trust and The Jerry Silva 2007 Annuity Trust, collectively, the stockholders of the Operating Company (the “Sellers”). Pursuant to the Stock Purchase Agreement, the Sellers sold to Paramount (now known as Chem Rx Corporation; i.e., the Issuer) all of the outstanding shares of the capital stock of the Operating Company in consideration for cash, shares of Common Stock of the Issuer and the right to earn additional cash and shares of Common Stock of the Issuer upon the achievement of certain targets relating to the EBITDA or stock price of the Issuer. Immediately upon consummation of the Transaction, Paramount changed its name to “Chem Rx Corporation.”

Item 4. Purpose of Transaction.

     The Trust may in the future earn the right to be issued additional shares of Issuer's Common Stock pursuant to the Stock Purchase Agreement. As a result of the Transaction and consistent with the terms and provisions of the Stock Purchase Agreement, Jerry Silva, Steven C. Silva, J. Jay Lobell, and David Kellman were appointed as directors of the Issuer. Reference is made to the disclosures in the Definitive Proxy Statement (No. 000-51518) filed by the Issuer with the Securities and Exchange Commission on October 2, 2007 under the caption “Directors and Executive Officers of Paramount Following the Transaction,” which is incorporated herein by reference.

      Lock-Up Covenant

     Under the terms of the Stock Purchase Agreement, the Trust will be restricted from transferring any shares of Common Stock of the Issuer for 180 days following the closing of the Transaction (the “Lock-up Covenant”). Upon the expiration of the 180-day period (i.e., April 23, 2008), the Lock-up Covenant will expire with respect to 50% of the total number of shares of Common Stock of the Issuer originally subject to the Lock-up Covenant. The Lock-up Covenant will expire with respect to 75% of the total number of shares of Common Stock originally subject to the Lock-up Covenant nine months after the closing (i.e., July 26, 2008) and will terminate with respect to the remaining shares on the first anniversary of the closing date (i.e., October 26, 2008).

      Contingent Right to Additional Shares

     Pursuant to the Stock Purchase Agreement, the Issuer will issue to the Sellers (including the Trust) the following shares pursuant to the provisions of the Stock Purchase Agreement referenced below:

(a)      An aggregate of up to 500,000 shares of Common Stock upon the circumstances provided in Section 1.8 of the Stock Purchase Agreement;

 




CUSIP No. 69917T103

Schedule 13D

Page 6 of 10



 

(b)      An aggregate of up to 5,500,000 shares of Common Stock upon the circumstances provided in Section 1.9(a) of the Stock Purchase Agreement; and

(c)      An aggregate of up to 3,000,000 shares of Common Stock upon the circumstances provided in Section 1.9(b) of the Stock Purchase Agreement.

As to any shares of Common Stock so issued, 5.874% of such shares would be issued to the Trust.

Item 5. Interest in Security of the Issuer.

(a) & (b) Because the Trust is a party to the Voting Agreement described in item 6, the Trust is deemed by Rule 13d-5(b)(1) of the Securities Exchange Act of 1934 to be the beneficial owner of all shares of the Issuer’s Common Stock beneficially owned by each party to the Voting Agreement. Therefore, as a result of such rule, the Trust may be deemed to have shared voting power over all of the 6,568,000 shares of the Issuer’s Common Stock subject to the Voting Agreement, which includes 1,993,000 shares of Common Stock issuable pursuant to warrants which are immediately exercisable. Such 6,568,000 of Common Stock shares represent approximately 40.1% of the outstanding shares of the Issuer’s Common Stock. The Trust disclaims beneficial ownership as to all of the shares of the Issuer’s Common Stock subject to the Voting Agreement, except the shares of Common Stock over which the Trust has dispositive power.

 

(c)     None.

 

(d)     No other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares owned by the Filer.

 

(e)     Not applicable.

Item 6.   Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

          Voting Agreement.

           Pursuant to a Voting Agreement, dated October 26, 2007 (the “Voting Agreement”), each of the stockholders party thereto agreed that, at any meeting of the stockholders of the Issuer, however called, and in any written action by consent of stockholders of the Issuer, such stockholder shall cause all shares of Common Stock of the Issuer then owned by it or its affiliates to be voted as provided in the Voting Agreement with respect to the election and re-election of certain persons as directors of the Issuer.




CUSIP No. 69917T103

Schedule 13D

Page 7 of 10



          For purposes of Section 13(d), a total of 6,568,000 shares of Common Stock may be deemed to be beneficially owned by virtue of the Voting Agreement, consisting of 4,575,000 shares of Common Stock currently outstanding and 1,993,000 shares of Common Stock issuable pursuant to exercise of immediately exercisable warrants. The number of such shares held by each party to the Voting Agreement is as follows:

Name

Shares as to which voting power is currently held

Additional Shares as to which voting power will be held after issuance u pon exercise of warrants

Jerry Silva

852,805

0

Steven Silva

656,890

0

The Jody R. Silva Trust

88,103

0

Jerry Silva, as Life Tenant, And Steven Silva, as Remainderman

635,865

0

The Jerry Silva 2007 Annuity Trust

166,337

0

Lindsay A. Rosenwald

584,375

1,304,574

Lindsay A. Rosenwald 2000 Family Trusts

584,375

 

J. Jay Lobell

318,750

395,523

I. Keith Maher

318,750

60,453

Michael Weiser

106,250

44,150

Arie Belldegrun

106,250

44,150

Isaac Kier

156,250

144,150

     

Total

4,575,000

1,993,000

     Registration Rights Agreement.

     Pursuant to a Registration Rights Agreement, dated October 26, 2007, the Issuer granted to the Sellers (including the Trust) certain piggyback and demand registration rights with respect to the shares of the Issuer’s Common Stock issued as consideration for their Operating Company securities. The Issuer has agreed to use its reasonable best efforts to become eligible to use Form S-3 (or any comparable successor form) under the Securities Act, as amended, and as soon as the Issuer becomes so eligible, the Issuer will (i) qualify and remain qualified to register securities on Form S-3 and (ii) file a shelf registration statement under Rule 415 of the Securities Act.

     Lock-Up Covenant and Contingent Right to Additional Shares.
 

     Reference is also made to (a) the restrictions on the right of the Trust to transfer shares of the Issuer's Common Stock as described in item 4 of this Schedule 13D under the caption "Lock-Up Covenant" and (b) the right of the Trust to acquire additional shares of the Issuer's Common Stock as described in item 4 of this Schedule 13D under the caption "Contingent Right to Additional Shares.”

 


CUSIP No. 69917T103

Schedule 13D

Page 8 of 10



     Except for the Stock Purchase Agreement, the Voting Agreement, the Registration Rights Agreement and the Lock-up Covenant, to the knowledge of the Trust, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Trust and any other person with respect to any securities of the Issuer, including, but not limited to, transfer or vote of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies.

Each of the Sellers under the Stock Purchase Agreement may also receive additional shares of Common Stock of the Issuer depending upon the achievement of certain future EBITDA or stock price targets by the Issuer. Any such shares would also be subject to the Voting Agreement

Item 7. Material to be Filed as Exhibits.

The following are exhibits to this Statement are incorporated herein by reference to the Report or Statement indicated in parenthesis:

Exhibit 7.1 -

Stock Purchase Agreement, dated as of June 1, 2007, as amended on October 8, 2007, among Paramount Acquisition Corp., B.J.K. Inc., and Jerry Silva, Steven C. Silva, Jerry Silva, as Life Tenant, and Steven C. Silva, as Remainderman, The Jody R. Silva Trust and The Jerry Silva 2007 Annuity Trust, collectively, the stockholders of the Operating Company (included as Annex A of the Proxy Statement (No. 000-51518) filed October 2, 2007 with the SEC and incorporated by reference herein).

Exhibit 7.2 -

Form of Voting Agreement (included as Annex F of the Proxy Statement (No. 000-51518) filed October 2, 2007 and incorporated by reference herein).

Exhibit 7.3 -

Form of Registration Rights Agreement (included as Annex D of the Proxy Statement (No. 000-51518) filed October 2, 2007 and incorporated by reference herein).




CUSIP No. 69917T103

Schedule 13D

Page 9 of 10



Signatures

     After reasonable inquiry and to the best of the knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this Statement is true, complete and correct.

Dated:     November 5, 2007
 

THE JODY R. SILVA TRUST

/s/ Rosalie Silva               

By: Rosalie Silva

Title: Trustee of The Jody R. Silva Trust




CUSIP No. 69917T103

Schedule 13D

Page 10 of 10



EXHIBIT INDEX

The following are exhibits to this Statement are incorporated herein my reference to the Report or Statement indicated in parenthesis:

Exhibit No.

Description

Exhibit 7.1 -

Stock Purchase Agreement, dated as of June 1, 2007, as amended on October 8, 2007, among Paramount Acquisition Corp., B.J.K. Inc., and Jerry Silva, Steven C. Silva, Jerry Silva, as Life Tenant, and Steven C. Silva, as Remainderman, The Jody R. Silva Trust and The Jerry Silva 2007 Annuity Trust, collectively, the stockholders of the Operating Company (included as Annex A of the Proxy Statement (No. 000-51518) filed October 2, 2007 with the SEC and incorporated by reference herein).

Exhibit 7.2 -

Form of Voting Agreement (included as Annex F of the Proxy Statement (No. 000-51518) filed October 2, 2007 and incorporated by reference herein).

Exhibit 7.3 -

Form of Registration Rights Agreement (included as Annex D of the Proxy Statement (No. 000-51518) filed October 2, 2007 and incorporated by reference herein).

-----END PRIVACY-ENHANCED MESSAGE-----